MKI67 and breast cancer: This study aimed at comparing the performance of different radiomic models in the prediction of the four most widely used molecular markers (ER, HER2, Ki67, PR) in BC management, using a two-step feature selection radiomic approach to extract meaningful mpMRI feature subsets.